India's Alembic Pharma rises on clean chit from US FDA
** Shares of India's Alembic Pharmaceuticals ALEM.NS up 2.2% to 898 rupees ** Drugmaker said U.S. Food and Drug Administration's October inspection at Panelav facility successfully completed, co received report ** Co set for 3% decline in April vs 25% jump in March, which broke its five-month losing streak ** YTD stock down ~16% (Reporting by Hritam Mukherjee in Bengaluru) ((Hritam.Mukherjee@thomsonreuters.com;))
Recent news on Alembic Pharmaceuticals
See all newsIndia's Alembic Pharma rises after US FDA approves herpesvirus drug
Brief: Alembic Pharmaceuticals Receives USFDA Final Approval For Valganciclovir Oral Solution 50 Mg/Ml
Brief: Alembic Pharmaceuticals Completes USFDA Bioequivalence Inspection At Vadodara With No Observations
India's Alembic Pharma gains as brokerages optimistic after quarterly profit rise
India's Alembic Pharma posts quarterly profit rise on strong generics demand